Vida Ventures II, LLC
SEC Form 4 insider trading activity
Vida Ventures II, LLC has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jan 12, 2026.
On the most recent filing, Vida Ventures II, LLC is listed as 10% Owner at Aktis Oncology, Inc. Inside the rolling window, Vida Ventures II, LLC reported 1 open-market purchase totaling $15.0M in AKTS and no open-market sales.
Companies traded
Other insiders at AKTS
Insider Buying
$15.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Vida Ventures II, LLC made?
Vida Ventures II, LLC has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.
Which companies does Vida Ventures II, LLC trade?
Vida Ventures II, LLC has filed SEC Form 4 disclosures for 1 company, including AKTS.
When was Vida Ventures II, LLC's most recent SEC Form 4 filing?
Vida Ventures II, LLC's most recent SEC Form 4 filing on Tracefour is dated Jan 12, 2026.
What is Vida Ventures II, LLC's total buy and sell value in the current window?
Inside the rolling retention window, Vida Ventures II, LLC bought $15.0M and sold $0 based on SEC Form 4 filings.
What was Vida Ventures II, LLC's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 835,000 AKTS shares on 2026-01-12, worth $15.0M, per SEC Form 4 filings.